Drugs News and Research

RSS

New clinical trial supports benefits of turmeric extract to people with osteoarthritis

A new clinical trial supports the benefits to people with osteoarthritis who used a unique extract of turmeric. Scientists in Italy have studied the pain-relief, increased flexibility, and other effects of a special, patented extract of the roots of turmeric, the flavorful spice that has been used for centuries as a traditional remedy. Turmeric formulations have shown a wide range of safety and significant scientific and clinical benefits in recent animal research and human clinical trials.

16 Sep 2010

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.

16 Sep 2010

HHS awards grant to develop patient-centered outcomes research

U.S. Department of Health and Human Services (HHS) Assistant Secretary for Health, Howard K. Koh, MD, MPH, today announced the award of more than $14 million to develop, implement, and test strategies to increase the adoption and dissemination of interventions based on patient-centered outcomes research among racial and ethnic minority populations.

16 Sep 2010

Renal research consortia receives two grants for translational research from DKF

The Dutch Kidney Foundation (DKF) awards two Consortium Grants of 1,5 million euro to renal research consortia to concentrate on translational research.

16 Sep 2010

ESMO honors three eminent cancer specialists for their contribution towards medical research

The European Society for Medical Oncology (ESMO) honors three eminent cancer specialists for their contribution to the advancement of medical research. The awards will be presented to Hilary Calvert, Alberto Costa and Bengt Glimelius at the 35th ESMO Congress, to take place from 8-12 October in Milan, Italy.

16 Sep 2010

Daily doses of ginger relieve muscle pain: Research

Daily doses of raw or heat-treated ginger are effective for relieving muscle pain following strenuous exercise, according to research reported in The Journal of Pain, published by the American Pain Society.

16 Sep 2010

Milwaukee sees fast rise in costs of benefits; N.J. Gov. outlines cuts to public workers' benefits; Hawaii teachers file suit over health changes

"The cost of health benefits appears to be rising at a much faster pace in the Milwaukee area than the national average. Employers reported that the cost of health benefits increased 11% to 13% on average in the Milwaukee area this year, according to the 2010 Greater Milwaukee Employer Health Care Benefits Survey

16 Sep 2010

Report: Prevention efforts averted almost 750,000 child Malaria deaths over 10 years

Malaria prevention efforts - such as the use of bed nets, indoor insecticide spraying and the use of drugs to prevent the disease - have prevented the deaths of almost 750,000 children in 34 African countries over the past 10 years, according to a report.

16 Sep 2010

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

K.U.Leuven announced today that on July 29th, 2010 they entered into a license agreement with Pfizer. The license agreement grants Pfizer exclusive and sublicenseable worldwide rights to further develop and commercialise K.U.Leuven's compounds with a new mechanism of action for the potential treatment of individuals infected with HIV, the virus that causes AIDS.

16 Sep 2010

Medicare confronts issues with prescription drug program and medical equipment purchases

Carper wrote to the Centers for Medicare and Medicaid Services on July 29 and requested the agency establish a process to ensure valid identification numbers on reimbursed prescriptions under the Part D program.

16 Sep 2010

Study finds aerobic exercise improves chronic insomnia

The millions of middle-aged and older adults who suffer from insomnia have a new drug-free prescription for a more restful night's sleep. Regular aerobic exercise improves the quality of sleep, mood and vitality, according to a small but significant new study from Northwestern Medicine.

16 Sep 2010

Scientists reveal techniques to extend organ transplant life

Experts from the Medical Research Council (MRC) Centre for Transplantation at King's College London, based at Guy's Hospital, have revealed exciting new scientific developments for people with an organ transplant, intended to help prevent rejection of the new organ and extend its life.

16 Sep 2010

Bruner to encourage FDA advisory committee to consider effectiveness of obesity drug Lorcaserin

On September 16, Denise Bruner, MD, FASBP will speak in favor of FDA approval for the new obesity drug Lorcaserin, during the open public hearing hour at the Endocrinologic and Metabolic Drug Advisory Committee meeting.

15 Sep 2010

Bohai adds additional pharmaceutical products to Traditional Chinese Medicine portfolio

Bohai Pharmaceuticals Group, Inc., a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announced the introduction of five additional pharmaceutical products to its portfolio of TCM offerings.

15 Sep 2010

Physicians rationalize acceptance of gifts as reward for sacrifices made in obtaining education

Despite heightened awareness about the undue influence that gifts from pharmaceutical companies can have on doctors' prescribing practices, and despite expanding institutional conflict-of-interest policies and state laws targeted at preventing such practices, companies continue to reward doctors for prescribing their drugs with gifts ranging from pens and paper, to free dinners and trips.

15 Sep 2010

BioCryst reports results from forodesine studies for CTCL and CLL

BioCryst Pharmaceuticals, Inc. announced preliminary top-line results from its multinational, open-label, single-arm trial evaluating 200 mg once-daily oral forodesine in the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL), as well as interim results from the Company's exploratory Phase 2 study to investigate the efficacy and safety of 200 mg twice-daily oral forodesine as monotherapy for chronic lymphocytic leukemia (CLL).

15 Sep 2010

ESMO honors eminent cancer specialists

15 Sep 2010

Harvard neurologist starts new program for doctor education; Study finds journal authors often do not disclose ties to medical device companies

The Boston Globe reports on Dr. Martin Samuels, a Harvard Medical School neurologist, who started "a new company that he says will provide continuing medical education to doctors across the country — without funding from the pharmaceutical industry.

15 Sep 2010

Study suggests decentralized clinics can reduce cost by offering mobile health services

Families from rural Mexico who receive health care from centralized clinics run by the federal government pay up to 30 percent less in out-of-pocket expenses and utilize preventive services more often than those families who access decentralized clinics run by states, according to a study by researchers at the UCLA School of Public Health.

15 Sep 2010

Scientist to develop antibiotics for drug-resistant superbugs

Antibiotics can work miracles, knocking out common infections like bronchitis and tonsillitis. But according to the Center for Disease Control, each year 90,000 people in the U.S. die of drug resistant "superbugs" bacteria like Staphylococcus aureus (MRSA), a deadly form of staph infection resistant to normal antibiotics. Although hospital patients are particularly susceptible as a result of open wounds and weakened immune systems, the bacteria can infect anyone. Dr. Micha Fridman of Tel Aviv University's Department of Chemistry is now developing the next generation of antibiotics designed to overcome this kind of bacteria. And the key, he says, is in the bacteria itself.

15 Sep 2010

Drugs News and Research

New clinical trial supports benefits of turmeric extract to people with osteoarthritis

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

HHS awards grant to develop patient-centered outcomes research

Renal research consortia receives two grants for translational research from DKF

ESMO honors three eminent cancer specialists for their contribution towards medical research

Daily doses of ginger relieve muscle pain: Research

Milwaukee sees fast rise in costs of benefits; N.J. Gov. outlines cuts to public workers' benefits; Hawaii teachers file suit over health changes

Report: Prevention efforts averted almost 750,000 child Malaria deaths over 10 years

K.U.Leuven enters license agreement with Pfizer to commercialize anti-HIV drugs

Medicare confronts issues with prescription drug program and medical equipment purchases

Study finds aerobic exercise improves chronic insomnia

Scientists reveal techniques to extend organ transplant life

Bruner to encourage FDA advisory committee to consider effectiveness of obesity drug Lorcaserin

Bohai adds additional pharmaceutical products to Traditional Chinese Medicine portfolio

Physicians rationalize acceptance of gifts as reward for sacrifices made in obtaining education

BioCryst reports results from forodesine studies for CTCL and CLL

ESMO honors eminent cancer specialists

Harvard neurologist starts new program for doctor education; Study finds journal authors often do not disclose ties to medical device companies

Study suggests decentralized clinics can reduce cost by offering mobile health services

Scientist to develop antibiotics for drug-resistant superbugs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News